Compare acids, combinations, and intended depth—not marketing names
Professional peels may use different acids or combinations, including formulas built around ingredients such as trichloroacetic, salicylic, retinoic, kojic, or other acids. The ingredient list alone does not define the full treatment. Concentration, pH, contact time, layers, application technique, and intended depth all influence how a peel behaves.
Brand names can be useful shorthand for a defined protocol, but they should not replace a current product check. Availability and formulations may change, and older descriptions may overstate who can use a product or what it will accomplish. Ruth Swissa should confirm the exact peel under consideration and clarify why it fits the assessed concern. The same branded family may contain distinct strengths or steps, making the precise protocol more relevant than name recognition.
The strongest option is not automatically the most effective choice. A superficial approach may better match limited downtime or a modest surface goal, while a deeper treatment introduces different recovery and risk. Comparison should begin with the skin and endpoint, then move to formulas capable of serving that plan. Previous peel response is valuable evidence: note the product if known, visible peeling, discomfort, duration of sensitivity, pigment changes, and whether the original concern improved.
Consider sensitivity, pigmentation risk, active conditions, and treatment history
Skin tone and a history of post-inflammatory color change matter when controlled injury is being considered. Sensitivity, active inflammation, barrier damage, infection, open areas, and difficult healing can also make a peel inappropriate or change its intensity. A professional assessment should not be replaced by a quiz that assigns a product from one concern.
Current routine and medical history add context. Retinoids, acne prescriptions, exfoliating products, prior reactions, recent waxing, lasers, injections, surgery, and sun exposure should be disclosed with dates. Medication decisions remain with the prescribing clinician, and another provider’s restrictions should be respected when treatments overlap.
Medical skin conditions and changing lesions need appropriate clinical care. A peel can be discussed for selected cosmetic surface concerns, but it should not be promoted as a universal treatment for melasma, acne scarring, rosacea, or another diagnosed condition. Those terms require more careful scope and, when relevant, dermatologic management.
Match preparation and downtime to the specific peel selected
Preparation should follow the selected formula and individual history rather than one checklist applied to every peel. Ruth can address nonprescription products, sun exposure, and procedure timing after choosing the approach. Clients should report any new irritation before the visit instead of trying to preserve the appointment at all costs.
Recovery may include temporary redness, sensitivity, dryness, or visible flaking, with depth and individual response influencing the course. A fixed day count cannot be promised from a category name. Work, travel, photographs, and events should be considered when deciding whether the proposed peel fits the calendar. Access to the practice after treatment can matter if the response differs from expectations.
Post-treatment directions need to identify gentle care, product timing, sun considerations, and how to contact the practice. Picking or accelerating visible peeling can work against recovery. For concerning symptoms, follow the provider's urgent-contact instructions rather than relying on general beauty advice.
Explore Ruth Swissa's professional peels and book a consultation so formula, risk, and recovery are weighed as one decision rather than three separate promises.